Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Orphan Europe Carbaglu® Surveillance Protocol

NCT03409003 is registered in ClinicalTrials.gov with Nicholas Ah Mew as lead sponsor.

NCT NCT03409003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03409003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Orphan Europe Carbaglu® Surveillance Protocol
Lead sponsor
Nicholas Ah Mew
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2012
Completion date
January 31, 2027
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

n-acetylglutamate synthase (nags) deficiency